Soren Ostergaard, Ph.D.

Principal Scientist, Research Chemistry 3 at Novo Nordisk A/S

Speaker

Soren Ostergaard is a principal scientist at Novo Nordisk A/S and has been working with peptide synthesis and technologies for +30 years. He is author or co-author of +85 publications, book chapter and patents/patent applications in the field of therapeutic peptides and proteins, half-life extension, protein-protein interactions, array technologies and combinatorial chemistry to name a few. His current research involves peptide drug design, for the treatment of metabolic disorders and rare diseases e.g., dual or triple acting properties, extended half-life as well as advancing high throughput peptide technologies. He is interacting with academia and serves as supervisor for PhD students. He is representing Novo Nordisk as talent ambassador at career events, giving educational lectures at medicinal chemistry courses at Universities in Denmark as well as serving a PhD assessor.